-
公开(公告)号:US20170325708A1
公开(公告)日:2017-11-16
申请号:US15589615
申请日:2017-05-08
申请人: Lenny Dang , Valeria Fantin , Stefan Gross , Hyun G. Jang , Shengfang Jin , Francesco G. Salituro , Jeffrey O. Saunders , Shin-San Michael Su , Katharine Yen
发明人: Lenny Dang , Valeria Fantin , Stefan Gross , Hyun G. Jang , Shengfang Jin , Francesco G. Salituro , Jeffrey O. Saunders , Shin-San Michael Su , Katharine Yen
IPC分类号: A61B5/055 , G01N33/574 , C12Q1/68 , A61K31/426 , C12Q1/32 , C12N15/113 , A61K45/06 , G06F19/00 , A61K31/41
CPC分类号: A61B5/055 , A61K31/41 , A61K31/426 , A61K45/06 , C12N15/1137 , C12N2310/14 , C12Q1/32 , C12Q1/6886 , C12Y101/01042 , G01N33/574 , G06F19/328 , Y02A90/24 , Y02A90/26 , A61K2300/00
摘要: Methods of treating and evaluating subjects having neoactive mutants are described herein.
-
2.
公开(公告)号:US20120121515A1
公开(公告)日:2012-05-17
申请号:US13256396
申请日:2010-03-12
申请人: Lenny Dang , Valeria Fantin , Stefan Gross , Hyun Gyung Jang , Shengfang Jin , Francesco G. Salituro , Jeffrey O. Saunders , Shinsan Su , Katharine Yen
发明人: Lenny Dang , Valeria Fantin , Stefan Gross , Hyun Gyung Jang , Shengfang Jin , Francesco G. Salituro , Jeffrey O. Saunders , Shinsan Su , Katharine Yen
CPC分类号: A61B5/055 , A61K31/41 , A61K31/426 , A61K45/06 , C12N15/1137 , C12N2310/14 , C12Q1/32 , C12Q1/6886 , C12Y101/01042 , G01N33/574 , G06F19/328 , Y02A90/24 , Y02A90/26 , A61K2300/00
摘要: Methods of treating and evaluating subjects having neoactive mutants are described herein.
摘要翻译: 本文描述了治疗和评估具有新生突变体的受试者的方法。
-
公开(公告)号:US09434979B2
公开(公告)日:2016-09-06
申请号:US13452136
申请日:2012-04-20
申请人: Shin-San Michael Su , Lenny Dang , Stefan Gross , Shengfang Jin , Valeria Fantin
发明人: Shin-San Michael Su , Lenny Dang , Stefan Gross , Shengfang Jin , Valeria Fantin
IPC分类号: A61K38/44 , C12Q1/32 , A61K31/225 , C12Q1/68 , A61K31/015 , A61K31/05 , A61K31/122 , A61K31/355 , A61K31/375 , A61K31/381 , A61K31/522 , A61K31/7004 , A61K31/713 , A61K38/06
CPC分类号: C12Q1/6886 , A61K31/015 , A61K31/05 , A61K31/122 , A61K31/194 , A61K31/225 , A61K31/355 , A61K31/375 , A61K31/381 , A61K31/522 , A61K31/7004 , A61K31/713 , A61K38/063 , A61K38/44 , C12Q1/32 , C12Q2600/106 , C12Q2600/112 , C12Q2600/118 , C12Q2600/136 , C12Q2600/156
摘要: Methods of treating and evaluating subjects having neoactive mutants of IDH (e.g., IDH1 or IDH2).
摘要翻译: 治疗和评估具有IDH(例如,IDH1或IDH2)的新生突变体的受试者的方法。
-
公开(公告)号:US20130183281A1
公开(公告)日:2013-07-18
申请号:US13452136
申请日:2012-04-20
申请人: Shin-San Michael Su , Lenny Dang , Stefan Gross , Shengfang Jin , Valeria Fantin
发明人: Shin-San Michael Su , Lenny Dang , Stefan Gross , Shengfang Jin , Valeria Fantin
IPC分类号: A61K38/44 , A61K31/713 , A61K31/375 , A61K38/06 , A61K31/05 , A61K31/522 , A61K31/015 , A61K31/355 , A61K31/122 , A61K31/7004 , A61K31/381
CPC分类号: C12Q1/6886 , A61K31/015 , A61K31/05 , A61K31/122 , A61K31/194 , A61K31/225 , A61K31/355 , A61K31/375 , A61K31/381 , A61K31/522 , A61K31/7004 , A61K31/713 , A61K38/063 , A61K38/44 , C12Q1/32 , C12Q2600/106 , C12Q2600/112 , C12Q2600/118 , C12Q2600/136 , C12Q2600/156
摘要: Methods of treating and evaluating subjects having neoactive mutants of IDH (e.g., IDH1 or IDH2).
摘要翻译: 治疗和评估具有IDH(例如,IDH1或IDH2)的新生突变体的受试者的方法。
-
5.
公开(公告)号:US20140187435A1
公开(公告)日:2014-07-03
申请号:US13939519
申请日:2013-07-11
申请人: Leonard Luan C. Dang , Valeria Fantin , Stefan Gross , Hyun Gyung Jang , Shengfang Jin , Francesco Gerald Salituro , Jeffrey Owen Saunders , Shin-San Michael Su , Katharine Yen
发明人: Leonard Luan C. Dang , Valeria Fantin , Stefan Gross , Hyun Gyung Jang , Shengfang Jin , Francesco Gerald Salituro , Jeffrey Owen Saunders , Shin-San Michael Su , Katharine Yen
CPC分类号: A61B5/055 , A61K31/41 , A61K31/426 , A61K45/06 , C12N15/1137 , C12N2310/14 , C12Q1/32 , C12Q1/6886 , C12Y101/01042 , G01N33/574 , G06F19/328 , Y02A90/24 , Y02A90/26 , A61K2300/00
摘要: Methods of treating and evaluating subjects having neoactive mutants are described herein.
摘要翻译: 本文描述了治疗和评估具有新生突变体的受试者的方法。
-
公开(公告)号:US20130288284A1
公开(公告)日:2013-10-31
申请号:US13617332
申请日:2012-09-14
申请人: Leonard Luan C Dang , Stefan Gross , Hyun Gyung Jang , Shengfang Jin , Shin-San Michael Su , Craig Thompson
发明人: Leonard Luan C Dang , Stefan Gross , Hyun Gyung Jang , Shengfang Jin , Shin-San Michael Su , Craig Thompson
IPC分类号: C12Q1/32
CPC分类号: C12Q1/6886 , A61K31/015 , A61K31/05 , A61K31/122 , A61K31/194 , A61K31/225 , A61K31/355 , A61K31/375 , A61K31/381 , A61K31/522 , A61K31/7004 , A61K31/713 , A61K38/063 , A61K38/44 , C12Q1/32 , C12Q2600/106 , C12Q2600/112 , C12Q2600/118 , C12Q2600/136 , C12Q2600/156
摘要: Methods of treating and evaluating subjects having neoactive mutants of IDH (e.g., IDH1 or IDH2).
-
公开(公告)号:US20130316385A1
公开(公告)日:2013-11-28
申请号:US13619387
申请日:2012-09-14
申请人: Lewis C. Cantley , Leonard Luan C Dang , Stefan Gross , Hyun Gyung Jang , Shengfang Jin , Shin-San Michael Su , Craig Thompson
发明人: Lewis C. Cantley , Leonard Luan C Dang , Stefan Gross , Hyun Gyung Jang , Shengfang Jin , Shin-San Michael Su , Craig Thompson
IPC分类号: C12Q1/32
CPC分类号: C12Q1/32 , A61K31/4184 , A61K31/428 , A61K31/519 , A61K31/5377 , A61K45/06 , A61K48/00 , C12N9/0006 , C12N15/1137 , C12N2310/14 , C12Q1/6886 , C12Q2600/106 , C12Q2600/156 , A61K2300/00
摘要: Methods and compositions for treating and evaluating subjects having a neoactive mutation at residue 97 of IDH1 or 137 of IDH2.
摘要翻译: 用于治疗和评估IDH2的IDH1或137残基97具有新突变的受试者的方法和组合物。
-
8.
公开(公告)号:US20150240286A1
公开(公告)日:2015-08-27
申请号:US14504983
申请日:2014-10-02
申请人: Leonard Luan C Dang , Stefan Gross , Hyun Gyung Jang , Shengfang Jin , Shin-San Michael Su , Craig Thompson
发明人: Leonard Luan C Dang , Stefan Gross , Hyun Gyung Jang , Shengfang Jin , Shin-San Michael Su , Craig Thompson
IPC分类号: C12Q1/32
CPC分类号: C12Q1/6886 , A61K31/015 , A61K31/05 , A61K31/122 , A61K31/194 , A61K31/225 , A61K31/355 , A61K31/375 , A61K31/381 , A61K31/522 , A61K31/7004 , A61K31/713 , A61K38/063 , A61K38/44 , C12Q1/32 , C12Q2600/106 , C12Q2600/112 , C12Q2600/118 , C12Q2600/136 , C12Q2600/156
摘要: Methods of treating and evaluating subjects having neoactive mutants of IDH (e.g., IDH1 or IDH2).
摘要翻译: 治疗和评估具有IDH(例如,IDH1或IDH2)的新生突变体的受试者的方法。
-
9.Method for diagnosing cell proliferation disorders having a neoactive mutation at residue 97 of isocitrate dehydrogenase 1 有权
标题翻译: 用于诊断在异柠檬酸脱氢酶1的残基97处具有新生突变的细胞增殖紊乱的方法公开(公告)号:US08883438B2
公开(公告)日:2014-11-11
申请号:US13619387
申请日:2012-09-14
申请人: Lewis C. Cantley , Leonard Luan C Dang , Stefan Gross , Hyun Gyung Jang , Shengfang Jin , Shin-San Michael Su , Craig Thompson
发明人: Lewis C. Cantley , Leonard Luan C Dang , Stefan Gross , Hyun Gyung Jang , Shengfang Jin , Shin-San Michael Su , Craig Thompson
IPC分类号: C12Q1/32
CPC分类号: C12Q1/32 , A61K31/4184 , A61K31/428 , A61K31/519 , A61K31/5377 , A61K45/06 , A61K48/00 , C12N9/0006 , C12N15/1137 , C12N2310/14 , C12Q1/6886 , C12Q2600/106 , C12Q2600/156 , A61K2300/00
摘要: Methods and compositions for treating and evaluating subjects having a neoactive mutation at residue 97 of IDH1 or 137 of IDH2.
摘要翻译: 用于治疗和评估IDH2的IDH1或137残基97具有新突变的受试者的方法和组合物。
-
公开(公告)号:US20100029734A1
公开(公告)日:2010-02-04
申请号:US12436210
申请日:2009-05-06
IPC分类号: A61K31/4184 , G01N33/574 , A61K31/41 , A61K31/401 , A61K31/165 , A61P35/00
CPC分类号: G01N33/57415 , G01N2333/515 , G01N2333/723 , G01N2800/52
摘要: A method for selecting a breast cancer patient for therapy with an agent that reduces production of angiotensin II, for example an ACE inhibitor or renin inhibitor, comprises (a) determining whether the cancer comprises a tumor that is estrogen receptor positive (ER+) and (b) selecting the patient for such therapy only if the cancer is determined to comprise an ER+ tumor. A method for treating breast cancer in a patient further comprises (c) administering to the patient, if so selected, an agent that reduces production of angiotensin II, for example an ACE inhibitor or renin inhibitor. A method for treating a breast tumor in a patient having SERM-resistant ER+ breast cancer comprises administering to the patient an agent that reduces production of angiotensin II, for example an ACE inhibitor or renin inhibitor. A therapeutic combination useful in treatment of a breast tumor comprises an agent that reduces production of angiotensin II, for example an ACE inhibitor or renin inhibitor, and a second agent that comprises (a) an aromatase inhibitor or (b) an estrogen receptor modulator or antagonist.
摘要翻译: 选择用于减少血管紧张素II生成剂(例如ACE抑制剂或肾素抑制剂)治疗的乳腺癌患者的方法包括(a)确定癌症是否包含雌激素受体阳性(ER +)和( b)仅当确定癌症包括ER +肿瘤时,才选择患者进行此类治疗。 用于治疗患者乳腺癌的方法进一步包括(c)如果这样选择,向患者施用减少血管紧张素II生成的试剂,例如ACE抑制剂或肾素抑制剂。 在具有SERM抗性ER +乳腺癌的患者中治疗乳腺肿瘤的方法包括向患者施用减少血管紧张素II产生的药物,例如ACE抑制剂或肾素抑制剂。 可用于治疗乳腺肿瘤的治疗组合包括减少血管紧张素II的产生的药物,例如ACE抑制剂或肾素抑制剂,以及第二药剂,其包含(a)芳香酶抑制剂或(b)雌激素受体调节剂或 拮抗剂。
-
-
-
-
-
-
-
-
-